{"disease":{"id":"amr","name":"amr"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06882070","title":"ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage","phase":"","overall_status":"COMPLETED","enrollment_count":1600,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT07261969","title":"CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan","phase":"NA","overall_status":"RECRUITING","enrollment_count":1050,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03388944","title":"PCT Guided Stopping of Antibiotic Therapy in Children With Sepsis","phase":"NA","overall_status":"COMPLETED","enrollment_count":561,"lead_sponsor_name":"All India Institute of Medical Sciences","has_results":false},{"nct_id":"NCT05475678","title":"Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":369,"lead_sponsor_name":"Zhenzhen Liu","has_results":false},{"nct_id":"NCT07393308","title":"Development and Implementation of Mobile Antibiograms to Optimize Empirical Antibiotic Prescriptions Among Prescribers in Tertiary Hospitals in Tanzania","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Muhimbili University of Health and Allied Sciences","has_results":false},{"nct_id":"NCT07177690","title":"A Study of the Impact of Penicillin Allergy on Antimicrobial Resistance and ouTcomes","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":214,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT07189429","title":"Clinical Impact Analysis of PA-100 AST in a Spanish GP Setting","phase":"NA","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Sysmex Europe GmbH","has_results":false},{"nct_id":"NCT06651047","title":"PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT06276933","title":"A Study of Camrelizumab Combined With Chemotherapy ± Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"Tongji University","has_results":false},{"nct_id":"NCT06485466","title":"TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":101,"lead_sponsor_name":"Guohui Xu","has_results":false},{"nct_id":"NCT05512481","title":"Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT06717594","title":"PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT05114707","title":"Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":57,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04889768","title":"HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":46,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT06744647","title":"Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05170542","title":"The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma.","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06061276","title":"bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03919539","title":"Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT02547220","title":"A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":39,"lead_sponsor_name":"Shire","has_results":true}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}